Clinical Trials

    Showing 1 - 2 of 2 Brain and Central Nervous System Cancers

    Phase I-II Study Evaluating HSV-tk + Valacyclovir Gene Therapy

    Status: Enrolling

    Investigator: David Baskin

    Study Coordinator: Melissa Daly

    Phone: 713.441.3834

    NCT03603405 This is a prospective, phase I-II study to assess the efficacy and toxicity of HSV-tk + valacyclovir gene therapy in combination with radiotherapy and standard of care chemotherapy for anaplastic astrocytoma (AA) or glioblastoma multifor... Read more >

    Phase I-II Study Evaluating HSV-tk + Valacyclovir Gene Therapy Combination with Radiotherapy and Chemotherapy for Recurrent Glioblastoma Multiforme

    Status: Enrolling

    Investigator: David Baskin

    Study Coordinator: Melissa Daly

    Phone: 713.441.3834

    NCT03596086 This is a prospective phase I-II study to assess the efficacy and toxicity of HSV-tk + valacyclovir gene therapy in combination with radiotherapy and standard of care chemotherapy in recurrent anaplastic astrocytoma or glioblastoma multi... Read more >